| Description | CR14011 is a human antibody binding for influenza B virus (IBV) and is capable of specifically binding and neutralizing at least one influenza B virus strain from the B/Victoria lineage and/or at least one influenza B virus strain from B/Yamagata lineage, and antigen-binding fragments thereof. CR14011 has broad NA inhibitory activity and is able to inhibit the NA activity of all type B viruses. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Influenza B virus (IBV) |
| Isotype | IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | FC; Inhib; ADCC |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | IBV |
| Alternative Name | Influenza B virus |
| Research Area | Microbiology |
